These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 15878975)
21. IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life. Bussel JB; Eldor A; Kelton JG; Varon D; Brenner B; Gillis S; Angiolillo A; Kulkarni R; Abshire TC; Kelleher J; Thromb Haemost; 2004 Apr; 91(4):771-8. PubMed ID: 15045139 [TBL] [Abstract][Full Text] [Related]
22. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura. Blanchette V; Carcao M Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140 [TBL] [Abstract][Full Text] [Related]
23. Massive intravascular haemolysis after high dose intravenous immunoglobulin therapy. Mohamed M; Bates G; Eastley B Br J Haematol; 2013 Mar; 160(5):570. PubMed ID: 23294261 [No Abstract] [Full Text] [Related]
24. Varicella-associated disseminated intravascular coagulation secondary to Henoch-Schönlein purpura with renal and gastrointestinal system involvement in a child: A case report. Jiang J; Liao K; Guo H; Chen XY Medicine (Baltimore); 2023 Nov; 102(46):e36203. PubMed ID: 37986286 [TBL] [Abstract][Full Text] [Related]
25. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Bussel JB; Graziano JN; Kimberly RP; Pahwa S; Aledort LM Blood; 1991 May; 77(9):1884-93. PubMed ID: 1850307 [TBL] [Abstract][Full Text] [Related]
26. A second case of post-transfusion purpura caused by HPA-5a antibodies: successful treatment with intravenous immunoglobulin. Ziman A; Klapper E; Pepkowitz S; Smith R; Garratty G; Goldfinger D Vox Sang; 2002 Aug; 83(2):165-6. PubMed ID: 12201847 [TBL] [Abstract][Full Text] [Related]
28. Acute renal failure in a child with thrombocytopenic purpura caused by acute Epstein-Barr virus infection after treatment with anti-D immunoglobulin. Kossiva L; Kyriakou D; Mitsioni A; Garoufi A Pediatr Emerg Care; 2013 Jun; 29(6):748-50. PubMed ID: 23736070 [TBL] [Abstract][Full Text] [Related]
29. Immunologic effects of anti-D (WinRho-SD) in children with immune thrombocytopenic purpura. Zimmerman SA; Malinoski FJ; Ware RE Am J Hematol; 1998 Feb; 57(2):131-8. PubMed ID: 9462545 [TBL] [Abstract][Full Text] [Related]
30. Quinine-induced disseminated intravascular coagulation: case report and review of the literature. Knower MT; Bowton DL; Owen J; Dunagan DP Intensive Care Med; 2003 Jun; 29(6):1007-1011. PubMed ID: 12682720 [TBL] [Abstract][Full Text] [Related]
31. Use of i.v. immune globulin and occurrence of associated acute renal failure and thrombosis. Shah S; Vervan M Am J Health Syst Pharm; 2005 Apr; 62(7):720-5. PubMed ID: 15790799 [TBL] [Abstract][Full Text] [Related]
32. Successful Treatment with Edoxaban for Disseminated Intravascular Coagulation in a Case of Aortic Dissection Complicated with Immune Thrombocytopenic Purpura. Uemura S; Kobayashi H; Seki Y; Okoshi Y; Sone H; Nomoto N Intern Med; 2020 Aug; 59(16):2035-2039. PubMed ID: 32389942 [TBL] [Abstract][Full Text] [Related]
33. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children. Freiberg A; Mauger D Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746 [TBL] [Abstract][Full Text] [Related]
34. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096 [TBL] [Abstract][Full Text] [Related]
35. A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children. Son DW; Jeon IS; Yang SW; Cho SH J Pediatr Hematol Oncol; 2008 Aug; 30(8):598-601. PubMed ID: 18799936 [TBL] [Abstract][Full Text] [Related]
36. Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy. Michel M; Novoa MV; Bussel JB Br J Haematol; 2003 Oct; 123(1):142-6. PubMed ID: 14510957 [TBL] [Abstract][Full Text] [Related]
37. Fc receptor blockade in patients with refractory chronic immune thrombocytopenic purpura with anti-D IgG. Ambriz-Fernández R; Martínez-Murillo C; Quintana-González S; Collazo-Jaloma J; Bautista-Juárez J Arch Med Res; 2002; 33(6):536-40. PubMed ID: 12505098 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials. Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658 [TBL] [Abstract][Full Text] [Related]
39. Renal insufficiency and failure associated with immune globulin intravenous therapy--United States, 1985-1998. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1999 Jun; 48(24):518-21. PubMed ID: 10401909 [TBL] [Abstract][Full Text] [Related]
40. Renal impairment, hemoglobinuria, and hemoglobinemia among patients with idiopathic thrombocytopenic purpura. Xue F; Wentworth C; Ganesh V; Gastanaga V; Stryker S; Cha S; Zhao S Am J Hematol; 2011 Sep; 86(9):738-42. PubMed ID: 21786287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]